Millennium Management
EDIT icon

Millennium Management’s Editas Medicine EDIT Stock Holding History

Millennium Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-162,330
Closed -$333K – 5871
2025
Q4 		$333K Sell
162,330
-173,458
-52% -$501K ﹤0.01% 5199
2025
Q3 		$1.17M Sell
335,788
-1,540,652
-82% -$4.3M ﹤0.01% 4503
2025
Q2 		$4.13M Buy
1,876,440
+1,590,955
+557% +$2.6M ﹤0.01% 3189
2025
Q1 		$331K Sell
285,485
-2,461,597
-90% -$3.62M ﹤0.01% 5045
2024
Q4 		$3.49M Sell
2,747,082
-603,774
-18% -$1.54M ﹤0.01% 3160
2024
Q3 		$11.4M Buy
3,350,856
+891,227
+36% +$3.88M 0.01% 2070
2024
Q2 		$11.5M Buy
2,459,629
+223,012
+10% +$1.26M 0.01% 1967
2024
Q1 		$16.6M Buy
2,236,617
+645,808
+41% +$5.37M 0.01% 1711
2023
Q4 		$16.1M Buy
1,590,809
+426,036
+37% +$3.74M 0.01% 1731
2023
Q3 		$9.09M Sell
1,164,773
-205,049
-15% -$1.76M ﹤0.01% 2134
2023
Q2 		$11.3M Buy
1,369,822
+85,885
+7% +$748K 0.01% 1899
2023
Q1 		$9.31M Sell
1,283,937
-858,531
-40% -$7.63M 0.01% 2029
2022
Q4 		$19M Buy
2,142,468
+259,598
+14% +$2.85M 0.01% 1490
2022
Q3 		$23M Buy
1,882,870
+1,731,710
+1,146% +$27M 0.01% 1219
2022
Q2 		$1.79M Sell
151,160
-596,501
-80% -$7.99M ﹤0.01% 3822
2022
Q1 		$14.2M Sell
747,661
-240,629
-24% -$4.47M 0.01% 1754
2021
Q4 		$26.2M Buy
988,290
+975,116
+7,402% +$33.6M 0.01% 1205
2021
Q3 		$541K Buy
+13,174
New +$722K ﹤0.01% 5270
2021
Q2 		– Sell
-204,919
Closed -$7.57M – 6640
2021
Q1 		$8.61M Buy
204,919
+144,794
+241% +$8.25M 0.01% 1953
2020
Q4 		$4.21M Buy
+60,125
New +$2.47M ﹤0.01% 2605
2020
Q3 		– Sell
-100,361
Closed -$2.97M – 4531
2020
Q2 		$2.97M Buy
100,361
+65,830
+191% +$1.72M ﹤0.01% 2221
2020
Q1 		$685K Sell
34,531
-33,573
-49% -$847K ﹤0.01% 2698
2019
Q4 		$2.02M Buy
68,104
+4,897
+8% +$122K ﹤0.01% 2616
2019
Q3 		$1.44M Buy
63,207
+20,982
+50% +$520K ﹤0.01% 2655
2019
Q2 		$1.04M Sell
42,225
-84,241
-67% -$2.01M ﹤0.01% 2783
2019
Q1 		$3.09M Buy
126,466
+53,223
+73% +$1.2M ﹤0.01% 2096
2018
Q4 		$1.67M Buy
+73,243
New +$1.99M ﹤0.01% 2301
2018
Q2 		– Sell
-310,109
Closed -$10.3M – 3863
2018
Q1 		$10.3M Sell
310,109
-112,648
-27% -$4.01M 0.01% 1307
2017
Q4 		$13M Buy
422,757
+49,336
+13% +$1.24M 0.02% 1154
2017
Q3 		$8.97M Buy
373,421
+208,773
+127% +$3.97M 0.01% 1314
2017
Q2 		$2.76M Sell
164,648
-400,051
-71% -$7.21M ﹤0.01% 1883
2017
Q1 		$12.6M Buy
564,699
+554,200
+5,279% +$11.5M 0.02% 906
2016
Q4 		$170K Sell
10,499
-29,501
-74% -$448K ﹤0.01% 3119
2016
Q3 		$539K Buy
40,000
+24,340
+155% +$499K ﹤0.01% 2570
2016
Q2 		$382K Buy
+15,660
New +$528K ﹤0.01% 2615

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management's EDIT Position: Q1 2026 in Review

Millennium Management sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 162,330 shares — an estimated $333K sold.

Millennium Management first reported a position in EDIT in Q2 2016 and held it in 35 quarters. The position peaked at $26.2M in Q4 2021. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

  • Millennium Management reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 162,330 Editas Medicine shares in Q1 2026, an estimated $333K.
  • Millennium Management first reported a position in Editas Medicine in Q2 2016 and held it in 35 quarters.
  • Millennium Management's Editas Medicine position peaked at $26.2M in Q4 2021.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.